About: RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.50 (+5.12%)
RNXT NASDAQ RenovoRx Inc
RenovoRx Inc share price
Atividade de preço de RNXT
Último preço
$ 1,500
Variação (24h)
0,07 USD (5,12%)
Volume
376.23K
Volume (média 4 sem.)
-
Abertura
$ 1,43
Variação do dia
$ 1,43 - $ 1,51
Fechamento anterior
$ 1,43
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
RNXT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals